Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

18. Mai 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3005


	Artikel 1 - 20 / 60086

	Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer. Discov Oncol Yadav B, Kollur SP, Ali A, Arora P, Gupta A, Saranraj P, Upadhye VJ, Singh P. PMID: 42149255 [PubMed - as supplied by publisher]
	PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance. Front Immunol Jin H, Huang H, Pan X. PMID: 42148077 [PubMed - indexed for MEDLINE]
	Evaluation of (68)Ga-DOTATATE and (18)F-FDG PET in grading non-functioning pancreatic neuroendocrine neoplasms <20 mm without metastasis. Quant Imaging Med Surg Zhou Y, Cao D, Ke NW, Tian R, Su MG. PMID: 42147920 [PubMed]
	Unraveling the Predictive Value of HGF, RECK, CYP1B1, and ZEB2 for Cancer Stemness and Immune Microenvironment in Pancreatic Adenocarcinoma. Stem Cells Int Chen H, Song S, Li C, Yu Z. PMID: 42147787 [PubMed]
	Diabetes and cancer: clinical implications for integrated metabolic-oncologic care. Front Oncol Fuchs-Tarlovsky V. PMID: 42147243 [PubMed]
	Association Between Liver Function Grade and Post-Hepatectomy Liver Failure in Patients With Hepatocellular Carcinoma: A Latent Class Analysis. Ann Gastroenterol Surg Liu L, Zheng J, Wang Y, Yang C, Zhang J, Jia C. PMID: 42146835 [PubMed]
	Ivonescimab and other anti-programmed death-1/ligand 1 (PD-(L)1)/vascular endothelial growth factor (VEGF) bispecific antibodies: progress and prospects in cancer therapy. Antib Ther Dong C, Wang X. PMID: 42145657 [PubMed]
	Atypical and suspicious diagnoses in solid pancreatic lesions: Cytomorphologic features and interobserver variability in FNA smears and biopsies. Cancer Cytopathol Al-Attar MM, Sardana R, Zhao M, Pitman MB, Torous VF, Chebib I, Zhang ML. PMID: 42145212 [PubMed - indexed for MEDLINE]
	Advances and applications of liquid biopsy approaches in hepatopancreatobiliary (HPB) cancers: a literature review. Chin Clin Oncol Hauptschein D, Uson Junior PLS, Borad MJ. PMID: 42145022 [PubMed - indexed for MEDLINE]
	Claudin 18.2 testing in gastroesophageal and pancreatobiliary cancers: current status, clinical implications and challenges. Chin Clin Oncol Lee SM, Wang H. PMID: 42145020 [PubMed - indexed for MEDLINE]
	Surgical management of pancreatic cancer: an overview. Chin Clin Oncol Kwok DCP, Chok KSH. PMID: 42145017 [PubMed - indexed for MEDLINE]
	Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma. Liver Int Chi QY, Gao XD, Wang M, Liu QY, Zeng YY, Yang LF, Liu ZJ, Wang SJ, Weng SG, Zhang ZB. PMID: 42144789 [PubMed - indexed for MEDLINE]
	Symptomatic presentation of cancer in patients diagnosed following emergency self-referral and prior general practice consultations. Postgrad Med Bosch X, Montori-Palacin E, Cadena-Rutllan M, Mota-Gomes T, Montoya M, Moreno P, Naval-Álvarez J, López-Soto A. PMID: 42144741 [PubMed - as supplied by publisher]
	Type 2 Diabetes, Glycemic Traits and Overall Cancer Risk: A Large-Scale Prospective Cohort Study. Cancer Med Zhang A, Zhu X, Li Z, Li Y, Zhu M, Yan C, Jin G, Cai P, Zhang M, Ding Y. PMID: 42144703 [PubMed - indexed for MEDLINE]
	Comparative study on PD-L1/ALK dual-targeted biomimetic exosomes by two preparation approaches in pancreatic cancer. Int J Biol Macromol Yuan C, Shi Y, Liu X, Zhao Y, Ruan Z, Luo L, Zhang L, Yao H, Li L. PMID: 42142782 [PubMed - as supplied by publisher]
	The Role of Cancer-Associated Fibroblasts in Various Cancer Drug Resistance. Cancer Lett Dang F, Na J, Xiao L, Tian X, Shao J, Zhong L, Zhao Y. PMID: 42142701 [PubMed - as supplied by publisher]
	Emerging concepts, hot topics, and open questions in today's pancreatic cancer research. Biochim Biophys Acta Rev Cancer Keber C, Schmitt M, Visekruna A, Brichkina A, von Strandmann EP, Bartsch JW, Huber M, Bauer UM, Gress TM, Lauth M. PMID: 42142668 [PubMed - as supplied by publisher]
	Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders. Biotechnol Adv Ren X, Zhou Z, Kong L, Guo Y, Liu Y, Li J, Gu X, Jiang C, Wu J. PMID: 42142549 [PubMed - as supplied by publisher]
	Risk of malignancy for biliary cytology based on World Health Organization (WHO) reporting system for pancreaticobiliary cytopathology. Cancer Cytopathol Abraham AE, Wang X, Hargett I, Pharaa Z, Sears C, Gonen M, Murali R, Lin O, Wei A, Gonzalez-Aguirre A, Shah P, Sigel C. PMID: 42142111 [PubMed - indexed for MEDLINE]
	A qualitative study on older patients' experiences and perceptions regarding the usability of wearable devices in tracking biometrics related to recovery after cancer surgery. J Geriatr Oncol Duin JJ, Verheijen D, Drewes YM, van Dam van Isselt EF, Mooijaart SP, Portielje JEA, Haaksma ML, van den Bos F. PMID: 42139850 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 60086

Seite 1 von 3005



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung